ArticleHepatology international2021
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan.
Chen-Hua Liu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papertrialcites it